OA
WST icon

Operose Advisors’s West Pharmaceutical WST Stock Holding History

Operose Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-44
Closed -$13.2K – 648
2024
Q3 		$13.2K Hold
44
– – ﹤0.01% 455
2024
Q2 		$14.5K Hold
44
– – 0.01% 394
2024
Q1 		$17.4K Hold
44
– – 0.01% 413
2023
Q4 		$15.5K Hold
44
– – 0.01% 406
2023
Q3 		$16.5K Buy
+44
New +$17K 0.01% 499

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Operose Advisors's WST Position: Q4 2024 in Review

Operose Advisors sold out of West Pharmaceutical (WST) in Q4 2024, closing a stake of 44 shares — an estimated $13.2K sold.

Operose Advisors first reported a position in WST in Q3 2023 and held it in 5 quarters. The position peaked at $17.4K in Q1 2024. 748 funds tracked by Wall St. Rank hold WST as of Q4 2024.

  • Operose Advisors reported no remaining West Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Operose Advisors sold 44 West Pharmaceutical shares in Q4 2024, an estimated $13.2K.
  • Operose Advisors first reported a position in West Pharmaceutical in Q3 2023 and held it in 5 quarters.
  • Operose Advisors's West Pharmaceutical position peaked at $17.4K in Q1 2024.
  • 748 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2024.

Based on Operose Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.